Security key
114082209
Ernexa Therapeutics Inc. - Common Stock (ERNA)
CUSIP: 114082209
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 333,250
- Total 13F value
- $750,186
- Share change
- +1,452
- SEC-reported price per share
- $2.26
- Number of holders
- 19
- Value change
- -$15,587
- Number of buys
- 6
- Number of sells
- 6
- Shares outstanding
- 1,166,181
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
19
Top holders
10
ERNA full security history
Ownership snapshot
Full 13F holder table
Ernexa Therapeutics Inc. SEC filings
Ernexa Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ERNA - Ernexa Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cypress Point Wealth Mana...
Disclosed value leader
Cypress Point Wealth Mana...
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 8.1%
Showing 1-6 of 15 holder rows.
Quick read
Cypress Point Wealth Management, LLC leads the comparable SEC ownership view at 8.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cypress Point Wealth Management, LLC's linked filing trail.
Comparable ownership
Top 5
Cypress Point Wealth Management, LLC
8.1%
Naviter Wealth, LLC
6.8%
Corient Private Wealth LLC
5.2%
BlackRock Finance, Inc.
2%
VANGUARD GROUP INC
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cypress Point Wealth Management, LLC |
13F
Company
|
8.1%
|
$320,875
94,375 shares
|
— | 31 Mar 2023 |
| Naviter Wealth, LLC |
13F
Company
|
6.8%
|
$270,864
79,666 shares
|
— | 31 Mar 2023 |
| Corient Private Wealth LLC |
13F
Company
|
5.2%
|
$214,071
61,189 shares
|
— | 31 Mar 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
2%
|
$79,434
23,363 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1.6%
|
$64,831
19,068 shares
|
— | 31 Mar 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.2%
|
$48,947
13,985 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
333,250
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
19
Q2 2023 holders
19
Holder diff
0
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|